Nebratamig (GNC-035) is an anti- ROR1 /anti- CD3 /anti- PD-L1 /anti- 4-1BB tetra-specific antibody with potential immunostimulatory and antineoplastic activities [1].
References:
[1]. https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nebratamig
References:
[1]. https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nebratamig
















